Last reviewed · How we verify
Hydroquinone Topical
Hydroquinone Topical is a Small molecule drug developed by University of California, Davis. It is currently FDA-approved. Also known as: Hydroquinone.
Hydroquinone Topical, developed by the University of California, Davis, is a marketed product with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence and ongoing patent protection. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Hydroquinone Topical |
|---|---|
| Also known as | Hydroquinone |
| Sponsor | University of California, Davis |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi (NA)
- Azelaic Acid 20% vs Hydroquinone 4% in Epidermal Melasma (NA)
- Fractionated 1927nm Laser for Hyperpigmentation in Fitzpatrick Skin Phototypes V and VI (NA)
- Prospective Evaluation of Topical Almond Oil vs Hydroquinone (PHASE4)
- Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study (PHASE2)
- Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid (NA)
- Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos (PHASE2)
- The Effectiveness of 3% Topical Tranexamic Acid Compared to 4% Topical Hydroquinone as Therapy of Melasma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hydroquinone Topical CI brief — competitive landscape report
- Hydroquinone Topical updates RSS · CI watch RSS
- University of California, Davis portfolio CI
Frequently asked questions about Hydroquinone Topical
What is Hydroquinone Topical?
Who makes Hydroquinone Topical?
Is Hydroquinone Topical also known as anything else?
What development phase is Hydroquinone Topical in?
Related
- Manufacturer: University of California, Davis — full pipeline
- Also known as: Hydroquinone
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing